Pooja Middha Kapoor
Overview
Explore the profile of Pooja Middha Kapoor including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
860
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang X, Chen H, Middha Kapoor P, Su Y, Bolla M, Dennis J, et al.
Cancer Res Commun
. 2022 Oct;
2(4):211-219.
PMID: 36303815
Background: Genome-wide association studies (GWAS) have identified more than 200 susceptibility loci for breast cancer, but these variants explain less than a fifth of the disease risk. Although gene-environment interactions...
2.
Wang X, Middha Kapoor P, Auer P, Dennis J, Dunning A, Wang Q, et al.
Sci Rep
. 2022 Apr;
12(1):6199.
PMID: 35418701
Use of menopausal hormone therapy (MHT) is associated with increased risk for breast cancer. However, the relevant mechanisms and its interaction with genetic variants are not fully understood. We conducted...
3.
Park H, Neumeyer S, Michailidou K, Bolla M, Wang Q, Dennis J, et al.
Br J Cancer
. 2021 Aug;
125(8):1135-1145.
PMID: 34341517
Background: Despite a modest association between tobacco smoking and breast cancer risk reported by recent epidemiological studies, it is still equivocal whether smoking is causally related to breast cancer risk....
4.
Coignard J, Lush M, Beesley J, OMara T, Dennis J, Tyrer J, et al.
Nat Commun
. 2021 May;
12(1):2986.
PMID: 33990587
A Correction to this paper has been published: https://doi.org/10.1038/s41467-021-23162-4.
5.
Coignard J, Lush M, Beesley J, OMara T, Dennis J, Tyrer J, et al.
Nat Commun
. 2021 Feb;
12(1):1078.
PMID: 33597508
Breast cancer (BC) risk for BRCA1 and BRCA2 mutation carriers varies by genetic and familial factors. About 50 common variants have been shown to modify BC risk for mutation carriers....
6.
Morra A, Jung A, Behrens S, Keeman R, Ahearn T, Anton-Culver H, et al.
Cancer Epidemiol Biomarkers Prev
. 2021 Jan;
30(4):623-642.
PMID: 33500318
Background: It is not known whether modifiable lifestyle factors that predict survival after invasive breast cancer differ by subtype. Methods: We analyzed data for 121,435 women diagnosed with breast cancer...
7.
Johnson N, Maguire S, Morra A, Middha Kapoor P, Tomczyk K, Jones M, et al.
Br J Cancer
. 2021 Jan;
124(4):842-854.
PMID: 33495599
Background: Epidemiological studies provide strong evidence for a role of endogenous sex hormones in the aetiology of breast cancer. The aim of this analysis was to identify genetic variants that...
8.
Dorling L, Carvalho S, Allen J, Gonzalez-Neira A, Luccarini C, Wahlstrom C, et al.
N Engl J Med
. 2021 Jan;
384(5):428-439.
PMID: 33471991
Background: Genetic testing for breast cancer susceptibility is widely used, but for many genes, evidence of an association with breast cancer is weak, underlying risk estimates are imprecise, and reliable...
9.
Zhang H, Ahearn T, Lecarpentier J, Barnes D, Beesley J, Qi G, et al.
Nat Genet
. 2020 May;
52(6):572-581.
PMID: 32424353
Breast cancer susceptibility variants frequently show heterogeneity in associations by tumor subtype. To identify novel loci, we performed a genome-wide association study including 133,384 breast cancer cases and 113,789 controls,...
10.
Middha Kapoor P, Mavaddat N, Pal Choudhury P, Wilcox A, Lindstrom S, Behrens S, et al.
J Natl Cancer Inst
. 2020 May;
113(3):329-337.
PMID: 32359158
We evaluated the joint associations between a new 313-variant PRS (PRS313) and questionnaire-based breast cancer risk factors for women of European ancestry, using 72 284 cases and 80 354 controls...